Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry pressures Greek government for dual pricing

This article was originally published in Scrip

Executive Summary

The Hellenic Association of Pharmaceutical Companies, SFEE, is behind a move to reintroduce dual pricing in Greece, said its president Dionysios Filiotis of Pharmaserve-Lilly. According to Mr Filiotis, drug prices would be based on the average of 16 Eurozone countries for one set of customers, and a "different" price for the social security funds. Mr Filiotis discussed the scheme as part of a wide-ranging interview with Scrip (see Face to Face 23 December 2010).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts